Tysabri 150mg Outside a Clinical Setting Administration HCP Guide
Healthcare Professional Guide to the risk of progressive multifocal leukoencephalopathy (PML) associated with TYSABRI (natalizumab). This supplement is intended for use by Healthcare Professionals (HCPs) administering TYSABRI subcutaneous (SC) outside a clinical setting (OCS).